Active Ingredient History
There is no available information related any biological and pharmaceutical application of ammonium tetrachlorozincate. NCATS
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Colitis, Ulcerative (approved 1955)
Dermatitis (approved 2006)
Gastrointestinal Diseases (approved 1987)
Renal Insufficiency (approved 2012)
Acne Vulgaris (Phase 2)
Alopecia (Phase 1/Phase 2)
Amyotrophic Lateral Sclerosis (Phase 1/Phase 2)
Anemia (Phase 4)
Anemia, Sickle Cell (Phase 3)
Antioxidants (Phase 4)
Attention Deficit Disorder with Hyperactivity (Phase 2/Phase 3)
Autistic Disorder (Phase 1)
beta-Thalassemia (Phase 3)
Cataract (Phase 3)
Central Serous Chorioretinopathy (Phase 2)
Child Development (Phase 3)
Child Nutrition Disorders (Phase 4)
Cholera (Phase 3)
Condylomata Acuminata (Phase 4)
Coronavirus (Phase 2)
Coronavirus Infections (Phase 2)
COVID-19 (Phase 4)
Critical Illness (Phase 3)
Deficiency Diseases (Phase 3)
Dermatology (Phase 4)
Diabetes Mellitus, Type 2 (Phase 2)
Diabetic Retinopathy (Phase 2)
Diarrhea (Phase 4)
Dysgeusia (Phase 3)
Endometriosis (Phase 2)
Enterocolitis, Necrotizing (Phase 4)
Fatigue Syndrome, Chronic (Phase 4)
Fever (Phase 3)
Gingival Diseases (Phase 3)
Gingivitis (Phase 3)
Graves Ophthalmopathy (Phase 2/Phase 3)
Growth (Phase 3)
Growth and Development (Phase 3)
Hepatitis, Alcoholic (Phase 2)
Hepatolenticular Degeneration (Phase 3)
Herpes Labialis (Phase 3)
HIV Infections (Phase 3)
Hospitalization (Phase 3)
Human papillomavirus 16 (Phase 4)
Hyaline Membrane Disease (Phase 4)
Hypogonadism (Phase 4)
Infections (Phase 2)
Infertility, Male (Phase 4)
Iron (Phase 4)
Iron Deficiencies (Phase 3)
Kallmann Syndrome (Phase 4)
Kidney Failure, Chronic (Phase 3)
Lichen Planus, Oral (Phase 4)
Lung Diseases (Phase 3)
Macular Degeneration (Phase 3)
Malaria (Phase 4)
Malnutrition (Phase 4)
Mucositis (Phase 3)
Pneumonia (Phase 4)
Poliovirus Vaccine, Oral (Phase 4)
Pregnancy (Phase 3)
Premature Birth (Phase 4)
Renal Insufficiency, Chronic (Phase 3)
Respiratory Tract Infections (Phase 4)
Rotavirus Infections (Phase 4)
Semen Analysis (Phase 4)
Sepsis (Phase 3)
Serum (Phase 2/Phase 3)
Severe Acute Respiratory Syndrome (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Subarachnoid Hemorrhage (Phase 3)
Thalassemia (Phase 2)
Thoracic Surgery (Phase 3)
Trace Elements (Phase 3)
Tuberculosis (Phase 3)
Vitamin A Deficiency (Early Phase 1)
Wounds and Injuries (Phase 3)
Zinc (Phase 4)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue